
© 2025 Der Aktionär
Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
Sa | Insider trades: JPMorgan, Bristol-Myers Squibb among notable names this week | ||
Fr | BMS shares overall survival results for Opdivo in phase 3 lung cancer trial | ||
Do | NICE changes its mind on BMS' lymphoma cell therapy | ||
Do | BioArctic's global license agreement with Bristol Myers Squibb for PyroGlutamate-amyloid-beta antibody program effective after antitrust clearance and closing | STOCKHOLM, Feb. 20, 2025 /PRNewswire/ -- BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) today announced that BioArctic and its partner Bristol Myers Squibb (NYSE: BMY) have received clearance... ► Artikel lesen | |
Mi | Bristol Myers Cancer Drug Opdivo In Combination With Chemo Shows Improved Overall Survival In Certain Patients With Lung Cancer |